Hereditary Transthyretin Amyloidosis (HATTR) Market, Global Outlook and Forecast 2024-2031

Report ID: 1134146 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hereditary Transthyretin Amyloidosis (HATTR) Overall Market Size
    2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size: 2021 VS 2028
    2.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market
    3.2 Top Global Hereditary Transthyretin Amyloidosis (HATTR) Companies Ranked by Revenue
    3.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Companies
    3.4 Top 3 and Top 5 Hereditary Transthyretin Amyloidosis (HATTR) Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Hereditary Transthyretin Amyloidosis (HATTR) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market
        3.6.1 List of Global Tier 1 Hereditary Transthyretin Amyloidosis (HATTR) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Markets, 2021 & 2028
        4.1.2 Oral
        4.1.3 Subcutaneous Injection
        4.1.4 Others
    4.2 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue & Forecasts
        4.2.1 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2022
        4.2.2 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2023-2028
        4.2.3 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue & Forecasts
        5.2.1 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2022
        5.2.2 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2023-2028
        5.2.3 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2021 & 2028
    6.2 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue & Forecasts
        6.2.1 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2022
        6.2.2 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2023-2028
        6.2.3 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2028
        6.3.2 US Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.3.3 Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.3.4 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2028
        6.4.2 Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.4.3 France Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.4.4 U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.4.5 Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.4.6 Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.4.7 Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.4.8 Benelux Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2028
        6.5.2 China Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.5.3 Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.5.4 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.5.5 Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.5.6 India Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2028
        6.6.2 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.6.3 Argentina Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2028
        6.7.2 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.7.3 Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.7.4 Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
        6.7.5 UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.1.4 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Alnylam Pharmaceuticals
        7.2.1 Alnylam Pharmaceuticals Corporate Summary
        7.2.2 Alnylam Pharmaceuticals Business Overview
        7.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.2.4 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.2.5 Alnylam Pharmaceuticals Key News
    7.3 Akcea Therapeutics
        7.3.1 Akcea Therapeutics Corporate Summary
        7.3.2 Akcea Therapeutics Business Overview
        7.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.3.4 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.3.5 Akcea Therapeutics Key News
    7.4 Prothena
        7.4.1 Prothena Corporate Summary
        7.4.2 Prothena Business Overview
        7.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.4.4 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.4.5 Prothena Key News
    7.5 Lonis Pharmaceuticals
        7.5.1 Lonis Pharmaceuticals Corporate Summary
        7.5.2 Lonis Pharmaceuticals Business Overview
        7.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.5.4 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.5.5 Lonis Pharmaceuticals Key News
    7.6 Eidos Therapeutics
        7.6.1 Eidos Therapeutics Corporate Summary
        7.6.2 Eidos Therapeutics Business Overview
        7.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.6.4 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.6.5 Eidos Therapeutics Key News
    7.7 Corino Therapeutics Inc
        7.7.1 Corino Therapeutics Inc Corporate Summary
        7.7.2 Corino Therapeutics Inc Business Overview
        7.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
        7.7.4 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2017-2022)
        7.7.5 Corino Therapeutics Inc Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Hereditary Transthyretin Amyloidosis (HATTR) Market Opportunities & Trends in Global Market
    Table 2. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers in Global Market
    Table 3. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints in Global Market
    Table 4. Key Players of Hereditary Transthyretin Amyloidosis (HATTR) in Global Market
    Table 5. Top Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Hereditary Transthyretin Amyloidosis (HATTR) Product Type
    Table 9. List of Global Tier 1 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 32. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
    Table 33. Alnylam Pharmaceuticals Corporate Summary
    Table 34. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 35. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
    Table 36. Akcea Therapeutics Corporate Summary
    Table 37. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 38. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
    Table 39. Prothena Corporate Summary
    Table 40. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 41. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
    Table 42. Lonis Pharmaceuticals Corporate Summary
    Table 43. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 44. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
    Table 45. Eidos Therapeutics Corporate Summary
    Table 46. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 47. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
    Table 48. Corino Therapeutics Inc Corporate Summary
    Table 49. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
    Table 50. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Type in 2021
    Figure 2. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application in 2021
    Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2021
    Figure 8. By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 12. US Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 16. Germany Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 17. France Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 24. China Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 28. India Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 30. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2017-2028
    Figure 33. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Hereditary Transthyretin Amyloidosis Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Transthyretin Amyloidosis Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Transthyretin Amyloidosis Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports